The document details the areas IHI should work on and guides IHI’s decisions on call topics.
Site Search
Site Search
The Children’s Tumor Foundation and the Global Coalition for Adaptive Research are making EU-PEARL’s model for a platform trial for patients with neurofibromatosis-1 (NF-1) and...
Respiratory syncytial virus – also known as RSV – may not be a widely known disease, yet its impact is significant. It can lead to serious chest infections and causes over 100 000...
IHI took part in the European Cancer Meeting 2022 of the French National Cancer Institute which was held in Paris, France, on 3 to 4 February 2022. It took place at the French, Economic, Social and...
Online tool allows scientists to monitor the numbers of people looking up respiratory syncytial virus (RSV) online – a useful indication of disease activity.
The two organisations have signed a Memorandum of Understanding that will facilitate collaboration and allow them to leverage their strengths, networks and expertise.
EU-backed researchers look into the most effective ways to minimise the spread of infectious diseases in healthcare environments.
The EMA’s Committee for Medicinal Products for Human Use recommendation for marketing authorisation means we are one step closer to treating adult patients with complicated intra...